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ABSTRACT Tinea incognita is a dermatophytic infection that is difficult to 
diagnose, usually modified by inappropriate topical or systemic corticoste-
roid therapy. We report an extensive case of tinea incognita caused by the 
zoophilic dermatophyte Trichophyton mentagrophytes (var. granulosa) in a 
49-year-old female patient with CREST (Calcinosis; Raynaud phenomenon; 
Esophageal involvement; Sclerodactyly; Teleangiectasia) syndrome. Immu-
nocompromised patients, as well as patients with keratinization disorders, 
seem to be especially susceptible to dermatophytic infections with atypi-
cal clinical presentation that is sometimes bizarre and difficult to recognize. 
Therefore, close monitoring and mycological skin examination is recom-
mended in order to avoid misdiagnosis and to give the patient the best 
chance of recovery.
KEY WORDS: Tinea incognita, Trichophyton mentagrophytes (var. granulosa), 
CREST 
INTRODUCTION
Tinea incognita is a dermatophytic infection that 
is difficult to diagnose, usually modified by inappro-
priate topical or systemic corticosteroid therapy. Ad-
ditionally, cases of tinea incognita induced by topical 
immunomodulators such as pimecrolimus (1,2) and 
tacrolimus (3) have been reported recently. Shortly 
after topical corticosteroids were introduced, the first 
cases of tinea incognita were described (4). Both im-
munocompetent and immunocompromised patients 
can be involved. 
The most frequently reported agent in Europe is 
the antropophilic dermatophyte Trichophyton rubrum 
(5,6). Zoophilic and even geophilic dermatophytes 
can also be implicated with tinea incognita (5,7). 
We report a case of an extensive tinea incognita 
caused by the zoophilic dermatophyte Trichophy-
ton mentagrophytes (var. granulosa) in a patient with 
CREST (Calcinosis; Raynaud phenomenon; Esopha-
geal involvement; Sclerodactyly; Teleangiectasia) 
syndrome. 
CASE REPORT
A 49-year-old female patient was referred to our 
Department due to extensive, erythematous, and not 
well demarcated lesions on the trunk, neck, and arms 
(Figure 1). Ichthyosiform scales and punctiform exco-
riations were observed as well. Prior to admission, the 
lesions had been unsuccessfully treated with topical 
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betamethasone cream. Very intensive pruritus in-
duced the patient to visit a dermatologist. 
Fifteen years earlier, the patient had been diag-
nosed with CREST syndrome with biliary cirrhosis and 
had been continuously receiving systemic steroids. 
Eventually, the maintenance dose became 10 mg of 
prednisone daily. Apart of the previously described 
skin lesions, the physical examination also revealed 
sclerodactyly and calcinosis of the fingers, with yel-
lowish discoloration of the nails (Figure 2). Numerous 
teleangiectasias were spread over the face, neck, up-
per trunk, and even the lips (Figure 3). 
Direct microscopic potassium hydroxide (KOH) ex-
amination of the skin scrapings was positive, reveal-
ing fungal hyphae. Trichophyton mentagrophytes (var. 
granulosa) was confirmed by cultureon the glucose-
modified Sabouraud medium. Direct examination 
and fungal culture of the nails were negative. Topi-
cal treatment with terbinafine cream was initiated. 
Systemic antimycotic therapy was not administered 
because of the very good response to the topical 
therapy and due to the high level of liver enzymes. 
After four weeks of treatment, a complete clinical and 
mycological regression was observed (Figure 4).
DISCUSSION
CREST syndrome is a clinical variant of sclero-
derma. It is not entirely a benign syndrome since 
esophageal dysfunction, pulmonary hypertension, 
and (as in our patient) biliary cirrhosis can occasion-
ally occur (8). Systemic immunosuppressive agents 
are sometimes used in order to ameliorate morbid-
ity and decrease potential mortality. In our patient, 
systemic and prolonged immunosuppression and 
inappropriate topical corticosteroid therapy resulted 
in extensive pruritic lesions with peculiar clinical ap-
pearance. The lesions were erythematous, not well 
demarcated, with ichthyosiform scaling, and excori-
ated due to the very intensive pruritus. The most fre-
quently isolated fungus in Europe is anthropophilic 
dermatophyte Trichophyton rubrum (5), whereas in 
our patient zoophilic Trichophyton mentagrophytes 
(var. granulosa) was confirmed by culture. However, 
no zoophilic source of infection could be detected, 
so the exact route of infection remained unclear in 
our patient. The unregistered or disregarded contact 
with the zoophilic source might have taken place in 
the patient’s history, and such a clinical presentation 
might have occurred due to the pre-existing keratini-
zation disorder. 
Figure 1. The trunk lesions (not well demarcated), 
with punctiform excoriations due to the very inten-
sive pruritus.
Figure 2. Sclerodactyly and calcinosis of the fingers 
with yellowish discoloration of the nails (part of the 
CREST syndrome).
Figure 3. Numerous teleangiectasias spread over the 
face (part of the CREST syndrome). 
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A case of tinea incognita has been also reported 
in a patient with pemphigus foliaceus on a potent 
topical and prolonged systemic steroid therapy. The 
reported lesions were pustular, extensive, and irri-
table, with less-raised margins and less scaly surface, 
resembling the basic ones due to the pemphigus fo-
liaceus (9). Unrecognized dermatophyte infections 
have been furthermore reported in patients with ich-
thyosis vulgaris and some other disorders of kerati-
nization (10,11). In those disorders, excessive keratin 
production seems to provide a more favorable habitat 
for fungi compared with normal skin (12). In patients 
with lupus erythematosus, fungal infections are also 
a major cause of morbidity. Disseminated dermato-
phytic infection due to Microsporum gypseum has 
been described in a patient with systemic lupus ery-
thematosus. Intrinsic immunological defects in lupus 
erythematosus and prolonged immunosuppressive 
therapy have been suggested as triggering factors 
(13).
Immunocompromised patients with HIV/AIDS 
seem to be especially susceptible to dermatophyte 
infections. Thus, widespread dermatophyte infec-
tions with atypical appearance, resistant to the con-
ventional therapy, have also been reported (7,14,15).
Tinea incognita is reported not only in immuno-
compromised patients, but also in otherwise healthy 
patients (16,17), including children (18-20). The clini-
cal appearance of such infections can mimic numer-
ous skin diseases, e.g. lupus erythematosus, eczema, 
rosacea psoriasis, purpura, seborrheic dermatitis, and 
lichen planus (5).  
CONCLUSION
Immunocompromized patients are susceptible to 
dermatophyte infections with atypical clinical presen-
tation. The clinical appearance is sometimes bizarre 
and difficult to recognize. Therefore, close monitoring 
and mycological skin examination is recommended 
in order to avoid misdiagnosis and to give the patient 
the best chance of recovery. 
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